AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012
Oct 26, 2012
33431_dirs_2012-10-26_e414c92d-ee50-4d99-8b0e-a398dc2c944c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-10-25
Reporting Person: SKINNER GREGORY S (VP Finance and Admin & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-25 | Common Stock | X | 125 | $5.63 | Acquired | 6786 | Indirect |
| 2012-10-25 | Common Stock | S | 6786 | $10.55 | Disposed | 0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-25 | Incentive Stock Option (Right to Buy) | $5.63 | X | 125 | Disposed | 2017-05-26 | Common Stock (125) | Indirect |
More from LIFECORE BIOMEDICAL, INC. \DE\
Regulatory Filings
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17